Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maya Inez Davis"'
Autor:
Jerrine R. Morris, Miriam Andrusier, Maya Inez Davis, Marcelle I. Cedars, Katie E. Aliaga, Amy Kaing, Heather G. Huddleston, Eleni Greenwood Jaswa, Lauri A. Pasch, Eduardo Hariton
Publikováno v:
Fertility and Sterility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955e6e636d51ec5c675422fcb21fcf97
https://doi.org/10.1016/j.fertnstert.2021.07.028
https://doi.org/10.1016/j.fertnstert.2021.07.028
Autor:
Romanos Sklavenitis-Pistofidis, Stephen E. Harding, Gad Getz, Maya Inez Davis, David L. Murray, Irene M. Ghobrial, D.J. Sakrikar, Jacqueline Perry, Catherine R. Marinac, Ciara Murphy, Timothy R. Rebbeck, Elizabeth D. Lightbody, David R. Barnidge, Tara Krause, Jean-Baptiste Alberge, Julia Amstutz, Annie Cowan, Prashant Kapoor, Mark C Perkins, Ivan Borrello, Mark Bustoros, Hadley Barr, Houry Leblebjian, Tarek H. Mouhieddine, Cody J. Boehner, Clifton C. Mo, Habib El-Khoury
Publikováno v:
Blood. 138:152-152
Background Multiple myeloma (MM) evolves from monoclonal gammopathy of undetermined significance (MGUS), a clinically detectable but asymptomatic premalignant phase seen in ~3% of the general population 50 years of age or older. The prevalence of MGU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0332f469eb469ee09156a7e89f60c91
https://doi.org/10.1182/blood-2021-149868
https://doi.org/10.1182/blood-2021-149868
Autor:
Molly Siegel, Simon Kleiner, Miriam Andrusier, Maura Jones, Eduardo Hariton, Maya Inez Davis, Demetra H. Hufnagel, Jerrine R. Morris, Katie E. Aliaga, Nazaneen Homaifar, Melissa G. Rosenstein
Publikováno v:
Fertility and Sterility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7f876a8a655ddf4d2e3f1c95b994c2a
https://doi.org/10.1016/j.fertnstert.2021.07.795
https://doi.org/10.1016/j.fertnstert.2021.07.795
Autor:
Donald F. Chute, Syeda Raji, Yaa Oppong, Sakuni T. Silva, Nifasha Rusibamayila, Sophia Zhao, Raymond T. Chung, Deborah Jean-Francois, Ravi Thadhani, Joshua D. Long, Meghan E. Sise, Maya Inez Davis
Publikováno v:
Kidney Int
Hepatitis C virus (HCV) infection is common and can accelerate chronic kidney disease (CKD) progression. Direct-acting antiviral (DAA) therapies against hepatitis C have consistently shown rates of sustained viral remission. However, the effect on ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8b27decfaf2a686a3663bd522305a7
https://europepmc.org/articles/PMC7094798/
https://europepmc.org/articles/PMC7094798/
